BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 21493123)

  • 1. The role of the pharmaceutical industry in meeting the public health threat of antibacterial resistance.
    Bergström R
    Drug Resist Updat; 2011 Apr; 14(2):77-8. PubMed ID: 21493123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The global need for effective antibiotics-a summary of plenary presentations.
    Alvan G; Edlund C; Heddini A
    Drug Resist Updat; 2011 Apr; 14(2):70-6. PubMed ID: 21440487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The global need for effective antibiotics-moving towards concerted action.
    Cars O; Hedin A; Heddini A
    Drug Resist Updat; 2011 Apr; 14(2):68-9. PubMed ID: 21444235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A framework for global surveillance of antibiotic resistance.
    Grundmann H; Klugman KP; Walsh T; Ramon-Pardo P; Sigauque B; Khan W; Laxminarayan R; Heddini A; Stelling J
    Drug Resist Updat; 2011 Apr; 14(2):79-87. PubMed ID: 21482177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The global need for effective antibiotics: challenges and recent advances.
    Högberg LD; Heddini A; Cars O
    Trends Pharmacol Sci; 2010 Nov; 31(11):509-15. PubMed ID: 20843562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards new business models for R&D for novel antibiotics.
    So AD; Gupta N; Brahmachari SK; Chopra I; Munos B; Nathan C; Outterson K; Paccaud JP; Payne DJ; Peeling RW; Spigelman M; Weigelt J
    Drug Resist Updat; 2011 Apr; 14(2):88-94. PubMed ID: 21439891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective antibacterials: at what cost? The economics of antibacterial resistance and its control.
    White AR;
    J Antimicrob Chemother; 2011 Sep; 66(9):1948-53. PubMed ID: 21700625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the antibacterial resistance crisis.
    Croft AC; D'Antoni AV; Terzulli SL
    Med Sci Monit; 2007 Jun; 13(6):RA103-18. PubMed ID: 17534243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial research and development in the 21(st) Century--an industry perspective of the challenges.
    Thomson CJ; Power E; Ruebsamen-Waigmann H; Labischinski H
    Curr Opin Microbiol; 2004 Oct; 7(5):445-50. PubMed ID: 15451498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing antimicrobial resistance through appropriate antibiotic usage in Singapore.
    Hsu LY; Kwa AL; Lye DC; Chlebicki MP; Tan TY; Ling ML; Wong SY; Goh LG
    Singapore Med J; 2008 Oct; 49(10):749-55. PubMed ID: 18946605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges of antibacterial discovery revisited.
    Gwynn MN; Portnoy A; Rittenhouse SF; Payne DJ
    Ann N Y Acad Sci; 2010 Dec; 1213():5-19. PubMed ID: 21058956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Currently available antimicrobial agents and their potential for use as monotherapy.
    Peterson LR
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():30-45. PubMed ID: 19040464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of development of new antimicrobial drugs: a potential serious threat to public health.
    Norrby SR; Nord CE; Finch R;
    Lancet Infect Dis; 2005 Feb; 5(2):115-9. PubMed ID: 15680781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotics: where did we go wrong?
    Overbye KM; Barrett JF
    Drug Discov Today; 2005 Jan; 10(1):45-52. PubMed ID: 15676298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fighting antibiotic resistance: marrying new financial incentives to meeting public health goals.
    Kesselheim AS; Outterson K
    Health Aff (Millwood); 2010 Sep; 29(9):1689-96. PubMed ID: 20820028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nature's clarion call of antibacterial resistance: are we listening?
    Theuretzbacher U; Toney JH
    Curr Opin Investig Drugs; 2006 Feb; 7(2):158-66. PubMed ID: 16499286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future antibiotics scenarios: is the tide starting to turn?
    Theuretzbacher U
    Int J Antimicrob Agents; 2009 Jul; 34(1):15-20. PubMed ID: 19342202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The need for new antibiotics.
    Livermore DM
    Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():1-9. PubMed ID: 15522034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostics as essential tools for containing antibacterial resistance.
    Okeke IN; Peeling RW; Goossens H; Auckenthaler R; Olmsted SS; de Lavison JF; Zimmer BL; Perkins MD; Nordqvist K
    Drug Resist Updat; 2011 Apr; 14(2):95-106. PubMed ID: 21398170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relentless rise of resistance?
    Wise R
    J Antimicrob Chemother; 2004 Aug; 54(2):306-10. PubMed ID: 15231764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.